Does Rallies show Form 4 insider transactions for TDOC?

Yes. Rallies tracks TDOC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TDOC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TDOC. It does not provide personalized investment advice.

TDOC (Teladoc Health, Inc.) Stock Analysis - Insider Trades

Teladoc Health, Inc. (TDOC) is a publicly traded Healthcare sector company. As of May 21, 2026, TDOC trades at $6.46 with a market cap of $1.15B and a P/E ratio of -5.64. TDOC moved -2.19% today. Year to date, TDOC is -10.99%; over the trailing twelve months it is -11.72%. Its 52-week range spans $4.40 to $15.21. Analyst consensus is buy with an average price target of $7.22. Rallies surfaces TDOC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TDOC stock inside the company?

Recent TDOC insider activity includes Catapano Joseph Ronald sold 675, DIVITA CHARLES III sold 27.73K, Rodrigues Fernando M. sold 25.09K, Vandervoort Adam C sold 27.08K, and Nueno Carlos sold 20.16K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TDOC Key Metrics

Key financial metrics for TDOC
Metric	Value
Price	$6.46
Market Cap	$1.15B
P/E Ratio	-5.64
EPS	$-1.14
Dividend Yield	0.00%
52-Week High	$15.21
52-Week Low	$4.40
Volume	919
Avg Volume	0
Revenue (TTM)	$2.53B
Net Income	$-200.32M
Gross Margin	0.00%

Recent TDOC Insider Trades

Catapano Joseph Ronald sold 675 (~$3.45K) on Apr 2, 2026.
DIVITA CHARLES III sold 27.73K (~$152.24K) on Mar 11, 2026.
Rodrigues Fernando M. sold 25.09K (~$124.98K) on Mar 3, 2026.
Vandervoort Adam C sold 27.08K (~$138.58K) on Mar 2, 2026.
Nueno Carlos sold 20.16K (~$103.18K) on Mar 2, 2026.

Latest TDOC News

Teladoc Health Q1: Integrated Care Up 2% to $395.4M, BetterHelp Down 9% — Apr 29, 2026
Hims Slumps 40% YTD to $20 After FDA Ban and Lower Q1 Guidance — Apr 10, 2026
Teladoc Health Shares Jump 4.4% After Deutsche Bank $11 Price Target Upgrade — Mar 10, 2026
Teladoc Q4 EPS Beats, Guides Q1 Sales Below Forecast; DB Sets $11 Target — Mar 10, 2026
Teladoc Health Upgraded to Buy with $11 Target on BetterHelp Turnaround — Mar 10, 2026

TDOC Analyst Consensus

22 analysts cover TDOC: 0 strong buy, 7 buy, 15 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.22.

Common questions about TDOC

Who is trading TDOC stock inside the company?: Recent TDOC insider activity includes Catapano Joseph Ronald sold 675, DIVITA CHARLES III sold 27.73K, Rodrigues Fernando M. sold 25.09K, Vandervoort Adam C sold 27.08K, and Nueno Carlos sold 20.16K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TDOC?: Yes. Rallies tracks TDOC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TDOC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TDOC. It does not provide personalized investment advice.